Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments (2017 - 2018)

Teva Pharmaceutical Industries has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $54.0 million for Q4 2018.

• Quarterly Preferred Dividend Payments fell 16.92% year-over-year to $54.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $249.0 million (down 4.23% YoY) and the FY2018 annual result came in at $249.0 million, down 4.23% from the prior year.
• Preferred Dividend Payments slipped to $54.0 million in Q4 2018, from $65.0 million in the prior quarter.
• Over five years, Preferred Dividend Payments peaked at $65.0 million in Q1 2017 and troughed at $54.0 million in Q4 2018.